Cell and Advanced Therapies Supply Chain Management Market Research Report, Forecast to 2030


Posted June 16, 2020 by Stella01wilson

Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030
 
Roots Analysis has done a detailed study on Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions (Cell Orchestration Platforms, Enterprise Manufacturing Systems, Inventory Management Systems, Laboratory Information Management Systems, Logistics Management Systems, Patient Management Systems, Quality Management Systems, Tracking & Tracing Systems, and Other Software), 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 510+ page report, which features 185+ figures and 400+ tables, please visit this link
Key Market Insights
• Presently, over 160 innovative, software-enabled systems are being used to efficiently manage and streamline various aspects of the complex supply chain of cell and advanced therapies
• Company involved in this domain are putting in significant efforts to develop advanced software solutions and also differentiate their offerings, from those of other industry players, in order to maintain a competitive edge
• North America is the major hub of innovation in this field, serving as the base for companies of all sizes, which are primarily engaged in developing cloud-based solutions for diverse applications
• The cell and advanced therapies market is characterized by an elaborate value chain, involving a multitude of processes and several stakeholders, each having a discrete set of priorities and requirements
• Increase in partnership activity reflects the growing interest of stakeholders in this industry; over 50% of reported deals were established to deploy software solutions for enhancing visibility and supply chain performance
• An analysis of recent activity on Twitter reveals the increasing interest and ongoing efforts of industry stakeholders in providing needle-to-needle traceability and supply chain orchestration solutions
• Given their cost saving potential across different processes and operations, we expect the cell and advanced therapy supply chain solutions market to grow at an annualized rate of around 25% over the next decade
• In the mid-long term, the projected opportunity is anticipated to be well distributed across various global regions, different end uses / applications and mode of deployment of various proprietary software solutions
For more information, please visit https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html
Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Context and Background
3.2. An Introduction to Cell and Advanced Therapies
3.2.1. Classification of Advanced Therapy Medicinal Products
3.2.2. Current Market Landscape
3.3. Overview of Cell and Advanced Therapies Supply Chain
3.3.1. Donor Eligibility and Selection
3.3.2. Sample Collection
3.3.3. Manufacturing
3.3.4. Logistics
3.3.5. Patient Verification and Treatment
3.3.6. Challenges Associated with the Cell and Advanced Therapies Supply Chain
3.3.6.1. Process Standardization
3.3.6.2. Packaging and Shipping Qualification
3.3.6.3. Validation of Storage Containers
3.3.6.4. Process Qualification
3.3.6.5. Chain of Custody Documentation
3.3.6.6. Demand Forecastin
3.4. Software Solutions for Cell and Advanced Therapies Supply Chain Management
3.4.1. Enterprise Manufacturing System
3.4.2. Laboratory Information Management System
3.4.3. Inventory Management System
3.4.4. Quality Management System
3.4.5. Logistics Management System
3.4.6. Patient Management System
3.4.7. Electronic Clinical Outcome Assessments System
3.4.8. Supply Chain Orchestration Platfor
3.5. Growth Drivers and Roadblocks
3.6. Recent Developments and Upcoming Trends
3.6.1. Blockchain Technology
3.6.2. Internet of Things
3.6.3. Augmented Reality
3.6.4. Big Data Analytics
3.6.5. Artificial Intelligence
4. CURRENT MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Cell and Advanced Therapies Supply Chain Management: Overall Market Landscape
4.2.1. Analysis by Type of Software Solution
4.2.2. Analysis by Key Specification and Benefits Offered
4.2.3. Analysis by Application
4.2.4. Analysis by Mode of Deployment
4.2.5. Analysis by Scale of Management
4.2.6. Analysis by Regulatory Certifications / Accreditations
4.2.7. Analysis by End User
4.3. Cell and Advanced Therapies Supply Chain Management: Developer Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Location of Headquarters
4.3.3. Analysis by Company Size
4.3.4. Analysis by Support Services Offered
4.3.5. Leading Developers: Analysis by Number of Software Solutions
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology
5.3. Assumptions and Key Input Parameters
5.4. Competitiveness Analysis: Software Solution Providers
5.4.1. COP Developers
5.4.2. EMS Developers
5.4.3. IMS Developers
5.4.4. LIMS Developers
5.4.5. LMS Developers
5.4.6. PMS Developers
5.4.7. QMS Developers
5.4.8. TTS Developers
6. CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT: COMPANY PROFILES
6.1. Chapter Overview
6.2. Brooks Life Sciences
6.2.1. Company Overview
6.2.2. Supply Chain Management Software Solution Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Cryoport
6.3.1. Company Overview
6.3.2. Financial Information
6.3.3. Supply Chain Management Software Solution Portfolio
6.3.4. Recent Developments and Future Outlook
6.4. MasterControl
6.4.1. Company Overview
6.4.2. Supply Chain Management Software Solution Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. SAP
6.5.1. Company Overview
6.5.2. Supply Chain Management Software Solution Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. Savsu Technologies
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Supply Chain Management Software Solution Portfolio
6.6.4. Recent Development and Future Outlook
6.7. TraceLink
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. Supply Chain Management Software Solution Portfolio
6.7.4. Recent Developments and Future Outlook
7. SUPPLY CHAIN ORCHESTRATION PLATFORM: EMERGING TRENDS AND KEY PLAYERS
7.1. Chapter Overview
7.2. Supply Chain Orchestration Platforms
7.2.1. Key Functions of Supply Chain Orchestration Platforms
7.2.2. Advantages of Supply Chain Orchestration Platforms
7.2.3. Supply Chain Orchestration Platform Implementation Strategies
7.2.3.1. Building the Required Foundation
7.2.3.2. Incorporating an Appropriate Scheduling System
7.2.3.3. Integration with Core Systems / Processe
7.3. Supply Chain Orchestration Platform: Social Media Trends
7.3.1. Scope and Methodology
7.3.2. Historical Trends in Volume of Tweets
7.3.3. Popular Keyword
7.4. Key Industry Players
7.4.1. Be The Match BioTherapies®
7.4.1.1. Company Overview
7.4.1.2. Financial Information
7.4.1.3. MatchSource®: Software Description
7.4.1.4. Recent Developments and Future Outloo
7.4.2. Clarkston Consulting
7.4.2.1. Company Overview
7.4.2.2. Cell Therapy Orchestration Platform: Software Description
7.4.2.3. Recent Developments and Future Outloo
7.4.3. Haemonetics
7.4.3.1. Company Overview
7.4.3.2. Financial Information
7.4.3.3. EdgeCell®: Software Description
7.4.3.4. Recent Developments and Future Outlook
7.4.4. Hypertrust Patient Data Care
7.4.4.1. Company Overview
7.4.4.2. Hypertrust X-Chain: Software Description
7.4.4.3. Recent Developments and Future Outloo
7.4.5. Lykan Bioscience
7.4.5.1. Company Overview
7.4.5.2. Unnamed Software: Software Description
7.4.5.3. Recent Developments and Future Outlook
7.4.6. MAK-SYSTEM
7.4.6.1. Company Overview
7.4.6.2. T.C.S.: Software Description
7.4.6.3. Recent Developments and Future Outlook
7.4.7. sedApta
7.4.7.1. Company Overview
7.4.7.2. O.S.A.: Software Description
7.4.7.3. Recent Developments and Future Outlook
7.4.8. Stafa Cellular Therapy
7.4.8.1. Company Overview
7.4.8.2. Stafa Cellular Therapy Lab: Software Description
7.4.8.3. Recent Developments and Future Outlook
7.4.9. Title 21 Health Solutions
7.4.9.1. Company Overview
7.4.9.2. Cell Therapy Software: Software Description
7.4.9.3. Recent Developments and Future Outlook
7.4.10. TrakCel
7.4.10.1. Company Overview
7.4.10.2. Financial Information
7.4.10.3. Cell Orchestration Platform: Software Description
7.4.10.4. Recent Developments and Future Outlook
7.4.11. Vineti
7.4.11.1. Company Overview
7.4.11.2. Financial Information
7.4.11.3. Personalized Therapy Management Platform: Software Description
7.4.11.4. Recent Developments and Future Outlook
8. FUNDING AND INVESTMENT ANALYSIS
8.1. Chapter Overview
8.2. Types of Funding
8.3. Cell and Advanced Therapies Supply Chain Management: Funding and Investment Analysis
8.3.1. Analysis by Number of Funding Instances
8.3.2. Analysis by Amount Invested
8.3.3. Analysis by Type of Funding
8.3.4. Analysis by Number of Funding Instances and Amount Invested across Different Software Solutions
8.3.5. Most Active Players: Analysis by Number of Funding Instances
8.3.6. Most Active Investors: Analysis by Number of Funding Instances
8.3.7. Geographical Analysis by Amount Invested
8.4. Concluding Remarks
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Cell and Advanced Therapies Supply Chain Management: Recent Collaborations and Partnerships
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Partner’s Focus Area
9.3.3.1. Analysis by Partner’s Focus Area
9.3.3.2. Analysis by Type of Platform and Partner’s Focus Area
9.3.3.3. Analysis by Type of Partnership Model and Partner’s Focus Area
9.3.4. Software Solution Analysis
9.3.4.1. Analysis by Type of Software Solutions
9.3.4.2. Analysis by Type of Platform and Partnership Model
9.3.5. Most Active Players: Analysis by Number of Partnerships
9.3.6. Geographical Analysis
9.3.6.1. Most Active Players
9.3.6.2. Intercontinental and Intracontinental Agreements
10. SUPPLY CHAIN UTILIZATION USE CASES
10.1. Chapter Overview
10.2. Cell and Advanced Therapies Supply Chain Management: Recent Platform Utilization Use Cases
10.2.1. Analysis by Year of Utilization
10.2.2. Analysis by Type of Partner
10.2.2.1. Most Active Users: Distribution by Number of Platform Utilization Instances
10.2.2.2. Geographical Distribution of Users

10.2.3. Analysis by Type of Software Solution
10.2.4. Most Active Players: Analysis by Number of Platform Utilization Agreements
10.2.5. Most Active Players: Regional Analysis by Number of Platform Utilization Agreements
10.2.5.1. Regional Distribution by Type of Software Solutions
10.2.5.2. Intercontinental and Intracontinental Agreements
11. STAKEHOLDER NEEDS ANALYSIS
11.1. Chapter Overview
11.2. Cell and Advanced Therapies Supply Chain Management: Needs of Different Stakeholders
11.2.1. Comparison of Stakeholder Needs
12. COST SAVINGS ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Overall Cost Saving Potential of Supply Chain Management Software Solutions, 2019-2030
12.3.1. Cost Saving Potential in Sample Collection and Processing, 2019-2030
12.3.2. Cost Saving Potential in Manufacturing, 2019-2030
12.3.3. Cost Saving Potential in Logistics, 2019-2030
12.3.4. Cost Saving Potential in Patient Verification and Treatment Follow-up, 2019-2030
13. MARKET FORECAST
13.1. Chapter Overview
13.2. Key Assumptions and Forecast Methodology
13.3. Overall Cell and Advanced Therapies Supply Chain Management Solutions Market, 2019-2030
13.3.1. Overall Cell and Advanced Therapies Supply Chain Management Solutions Market: Distribution by Application
13.3.1.1. Cell and Advanced Therapies Supply Chain Management Solutions Market for Sample Collection and Processing, 2019-2030
13.3.1.2. Cell and Advanced Therapies Supply Chain Management Solutions Market for, Manufacturing, 2019-2030
13.3.1.3. Cell and Advanced Therapies Supply Chain Management Solutions Market for, Logistics, 2019-2030
13.3.1.4. Cell and Advanced Therapies Supply Chain Management Solutions Market for Patient Verification and Treatment Follow-up, 2019-2030
13.3.2. Overall Cell and Advanced Therapies Supply Chain Management Solutions Market: Distribution by End User
13.3.2.1. Cell and Advanced Therapies Supply Chain Management Solutions Market for Biobanks, 2019-2030
13.3.2.2. Cell and Advanced Therapies Supply Chain Management Solutions Market for Cell Therapy Labs / Commercial Organizations, 2019-2030
13.3.2.3. Cell and Advanced Therapies Supply Chain Management Solutions Market for Hospitals / Medical Centers, 2019-2030
13.3.2.4. Cell and Advanced Therapies Supply Chain Management Solutions Market for Research Institutes, 2019-2030
13.3.3. Overall Cell and Advanced Therapies Supply Chain Management Solutions Market: Distribution by Type of Software Solution
13.3.3.1. Cell Orchestration Platforms Market for Cell and Advanced Therapies Supply Chain Management, 2019-2030
13.3.3.2. Enterprise Manufacturing Systems Market for Cell and Advanced Therapies Supply Chain Management, 2019-2030
13.3.3.3. Inventory Management Systems Market for Cell and Advanced Therapies Supply Chain Management, 2019-2030
13.3.3.4. Laboratory Information Management Systems Market for Cell and Advanced Therapies Supply Chain Management, 2019-2030
13.3.3.5. Logistics Management Systems Market for Cell and Advanced Therapies Supply Chain Management, 2019-2030
13.3.3.6. Patient Management Systems Market for Cell and Advanced Therapies Supply Chain Management, 2019-2030
13.3.3.7. Quality Management Systems Market for Cell and Advanced Therapies Supply Chain Management, 2019-2030
13.3.4. Overall Cell and Advanced Therapies Supply Chain Management Solutions Market: Distribution by Mode of Deployment
13.3.4.1. Cell and Advanced Therapies Supply Chain Management Market for Cloud-based Solutions, 2019-2030
13.3.4.2. Cell and Advanced Therapies Supply Chain Management Market for On-premises Solutions, 2019-2030
13.3.5. Overall Cell and Advanced Therapies Supply Chain Management Solutions Market: Distribution by Scale of Operation
13.3.5.1. Cell and Advanced Therapies Supply Chain Management Market for Clinical Therapies, 2019-2030
13.3.5.2. Cell and Advanced Therapies Supply Chain Management Market for Commercial Therapies, 2019-2030
13.3.6. Overall Cell and Advanced Therapies Supply Chain Management Solutions Market: Distribution by Geography
13.3.6.1. Cell and Advanced Therapies Supply Chain Management Solutions Market in North America, 2019-2030
13.3.6.2. Cell and Advanced Therapies Supply Chain Management Solutions Market in Europe, 2019-2030
13.3.6.3. Cell and Advanced Therapies Supply Chain Management Solutions Market in Asia-Pacific, 2019-2030
13.3.6.4. Cell and Advanced Therapies Supply Chain Management Solutions Market in Rest of the World, 2019-2030
13.4. Overall Cell and Advanced Therapies Supply Chain Management Solutions Market: Distribution by Application, Type of Software Solution and Mode of Deployment
13.4.1. Cell and Advanced Therapies Supply Chain Management Solutions Market for Sample Collection and Processing, 2019-2030
13.4.1.1. Cell Orchestration Platforms Market for Sample Collection and Processing, 2019-2030
13.4.1.1.1. Cell Orchestration Platforms Market for Sample Collection and Processing: Cloud-based Solutions, 2019-2030
13.4.1.1.2. Cell Orchestration Platforms Market for Sample Collection and Processing: On-premises Solutions, 2019-2030
13.4.1.2. Enterprise Manufacturing Systems Market for Sample Collection and Processing, 2019-2030
13.4.1.2.1. Enterprise Manufacturing Systems Market for Sample Collection and Processing: Cloud-based Solutions, 2019-2030
13.4.1.2.2. Enterprise Manufacturing Systems Market for Sample Collection and Processing: On-premises Solutions, 2019-2030

13.4.1.3. Inventory Management Systems Market for Sample Collection and Processing, 2019-2030
13.4.1.3.1. Inventory Management Systems Market for Sample Collection and Processing: Cloud-based Solutions, 2019-2030
13.4.1.3.2. Inventory Management Systems Market for Sample Collection and Processing: On-premises Solutions, 2019-2030
13.4.1.4. Laboratory Information Management Systems Market for Sample Collection and Processing, 2019-2030
13.4.1.4.1. Laboratory Information Management Systems Market for Sample Collection and Processing: Cloud-based Solutions, 2019-2030
13.4.1.4.2. Laboratory Information Management Systems Market for Sample Collection and Processing: On-premises Solutions, 2019-2030
13.4.1.5. Logistics Management Systems Market for Sample Collection and Processing, 2019-2030
13.4.1.5.1. Logistics Management Systems Market for Sample Collection and Processing: Cloud-based Solutions, 2019-2030
13.4.1.5.2. Logistics Management Systems Market for Sample Collection and Processing: On-premises Solutions, 2019-2030
13.4.1.6. Patient Management Systems Market for Sample Collection and Processing, 2019-2030
13.4.1.6.1. Patient Management Systems Market for Sample Collection and Processing: Cloud-based Solutions, 2019-2030
13.4.1.6.2. Patient Management Systems Market for Sample Collection and Processing: On-premises Solutions, 2019-2030
13.4.1.7. Quality Management Systems Market for Sample Collection and Processing, 2019-2030
13.4.1.7.1. Quality Management Systems Market for Sample Collection and Processing: Cloud-based Solutions, 2019-2030
13.4.1.7.2. Quality Management Systems Market for Sample Collection and Processing: On-premises Solutions, 2019-2030
13.4.2. Cell and Advanced Therapies Supply Chain Management Solutions Market for Manufacturing, 2019-2030
13.4.2.1. Cell Orchestration Platforms Systems Market for Manufacturing, 2019-2030
13.4.2.1.1. Cell Orchestration Platforms Systems Market for Manufacturing: Cloud-based Solutions, 2019-2030
13.4.2.1.2. Cell Orchestration Platforms Systems Market for Manufacturing: On-premises Solutions, 2019-2030
13.4.2.2. Enterprise Manufacturing Systems Market for Manufacturing, 2019-2030
13.4.2.2.1. Enterprise Manufacturing Systems Market for Manufacturing: Cloud-based Solutions, 2019-2030
13.4.2.2.2. Enterprise Manufacturing Systems Market for Manufacturing: On-premises Solutions, 2019-2030
13.4.2.3. Inventory Management Systems Market for Manufacturing, 2019-2030
13.4.2.3.1. Inventory Management Systems Market for Manufacturing: Cloud-based Solutions, 2019-2030
13.4.2.3.2. Inventory Management Systems Market for Manufacturing: On-premises Solutions, 2019-2030

13.4.2.4. Laboratory Information Management Systems Market for Manufacturing, 2019-2030
13.4.2.4.1. Laboratory Information Management Systems Market for Manufacturing: Cloud-based Solutions, 2019-2030
13.4.2.4.2. Laboratory Information Management Systems Market for Manufacturing: On-premises Solutions, 2019-2030
13.4.2.5. Logistics Management Systems Market for Manufacturing, 2019-2030
13.4.2.5.1. Logistics Management Systems Market for Manufacturing: Cloud-based Solutions, 2019-2030
13.4.2.5.2. Logistics Management Systems Market for Manufacturing: On-premises Solutions, 2019-2030
13.4.2.6. Patient Management Systems Market for Manufacturing, 2019-2030
13.4.2.6.1. Patient Management Systems Market for Manufacturing: Cloud-based Solutions, 2019-2030
13.4.2.6.2. Patient Management Systems Market for Manufacturing: On-premises Solutions, 2019-2030
13.4.2.7. Quality Management Systems Market for Manufacturing, 2019-2030
13.4.2.7.1. Quality Management Systems Market for Manufacturing: Cloud-based Solutions, 2019-2030
13.4.2.7.2. Quality Management Systems Market for Manufacturing: On-premises Solutions, 2019-2030
13.4.3. Cell and Advanced Therapies Supply Chain Management Solutions Market for Logistics, 2019-2030
13.4.3.1. Cell Orchestration Platforms Market for Logistics, 2019-2030
13.4.3.1.1. Cell Orchestration Platforms Market for Logistics: Cloud-based Solutions, 2019-2030
13.4.3.1.2. Cell Orchestration Platforms Market for Logistics: On-premises Solutions, 2019-2030
13.4.3.2. Enterprise Manufacturing Systems Market for Logistics, 2019-2030
13.4.3.2.1. Enterprise Manufacturing Systems Market for Logistics: Cloud-based Solutions, 2019-2030
13.4.3.2.2. Enterprise Manufacturing Systems Market for Logistics: On-premises Solutions, 2019-2030
13.4.3.3. Inventory Management Systems Market for Logistics, 2019-2030
13.4.3.3.1. Inventory Management Systems Market for Logistics: Cloud-based Solutions, 2019-2030
13.4.3.3.2. Inventory Management Systems Market for Logistics: On-premises Solutions, 2019-2030
13.4.3.4. Laboratory Information Management Systems Market for Logistics, 2019-2030
13.4.3.4.1. Laboratory Information Management Systems Market for Logistics: Cloud-based Solutions, 2019-2030
13.4.3.4.2. Laboratory Information Management Systems Market for Logistics: On-premises Solutions, 2019-2030
13.4.3.5. Logistics Management Systems Market for Logistics, 2019-2030
13.4.3.5.1. Logistics Management Systems Market for Logistics: Cloud-based Solutions, 2019-2030
13.4.3.5.2. Logistics Management Systems Market for Logistics: On-premises Solutions, 2019-2030

13.4.3.6. Patient Management Systems Market for Logistics, 2019-2030
13.4.3.6.1. Patient Management Systems Market for Logistics: Cloud-based Solutions, 2019-2030
13.4.3.6.2. Patient Management Systems Market for Logistics: On-premises Solutions, 2019-2030
13.4.4. Cell and Advanced Therapies Supply Chain Management Solutions Market for Patient Verification and Treatment Follow-up, 2019-2030
13.4.4.1. Cell Orchestration Platforms Market for Patient Verification and Treatment Follow-up, 2019-2030
13.4.4.1.1. Cell Orchestration Platforms Market for Patient Verification and Treatment Follow-up: Cloud-based Solutions, 2019-2030
13.4.4.1.2. Cell Orchestration Platforms Market for Patient Verification and Treatment Follow-up: On-premises Solutions, 2019-2030
13.4.4.2. Inventory Management Systems Market for Patient Verification and Treatment Follow-up, 2019-2030
13.4.4.2.1. Inventory Management Systems Market for Patient Verification and Treatment Follow-up: Cloud-based Solutions, 2019-2030
13.4.4.2.2. Inventory Management Systems Market for Patient Verification and Treatment Follow-up: On-premises Solutions, 2019-2030
13.4.4.3. Patient Management Systems Market for Patient Verification and Treatment Follow-up, 2019-2030
13.4.4.3.1. Patient Management Systems Market for Patient Verification and Treatment Follow-up: Cloud-based Solutions, 2019-2030
13.4.4.3.2. Patient Management Systems Market for Patient Verification and Treatment Follow-up: On-premises Solutions, 2019-2030
14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Thermo Fisher Scientific
14.2.1. Company Snapshot
14.2.2. Interview Transcript: Bryan Poltilove, Former General Manager, Cell and Gene Therapy
14.3. Cell and Gene Therapy Catapult
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Jacqueline Barry, Chief Clinical Officer
14.4. McKesson
14.4.1. Company Snapshot
14.4.2. Interview Transcript: Divya Iyer, Senior Director, Corporate Strategy and Business Development, and Jill Maddux, Director, Cell and Gene Therapy Product Strategy
14.5. TrakCel
14.5.1. Company Snapshot
14.5.2. Interview Transcript: Martin Lamb, Former Chief Business Officer
15. CONCLUDING REMARKS
15.1. Chapter Overview
15.2. Key Takeaways
16. APPENDIX 1: LIST OF ADDITIONAL SUPPLY CHAIN MANAGEMENT SOFTWARE SOLUTIONS
17. APPENDIX 2: TABULATED DATA
18. APPENDIX 3: LIST OF COMPANIES AND ORGANIZATIONS
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]
-- end ---
Contact Email [email protected]
Issued By Roots Analysis
Phone +1 (415) 800 3415
Country Mozambique
Categories Business , Industry , Medical
Tags Cell and Advanced Therapies Supply Chain Management , Cell and Advanced Therapies Supply Chain Management Market , Cell and Advanced Therapies Supply Chain Management Market Trends
Last Updated June 16, 2020